---
title: "Merit Medical to acquire Pentax Medical’s C2 CryoBalloon technology"
date: "2025-10-16T15:03:19.000Z"
publishedDate: "16 octobre 2025"
summary: "Pentax Medical has today announced an asset purchase agreement with Merit Medical Systems for the acquisition of the C2 CryoBalloon technology. The C2 CryoBalloon has been part of Pentax Medical&#8217;s therapeutic portfolio since 2017, offering a minimally invasive option to treat patients suffering from Barrett&#8217;s Esophagus and other gastrointestinal disorders."
importance: ""
sourceUrl: "https://interventionalnews.com/merit-medical-to-acquire-pentax-medicals-c2-cryoballoon-technology/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-10-16-merit-medical-to-acquire-pentax-medicals-c2-cryoballoon-technology"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2025/07/Merit-Medical-logo-766x512.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/merit-medical-to-acquire-pentax-medicals-c2-cryoballoon-technology/"
---

![Merit Medical to acquire Pentax Medical’s C2 CryoBalloon technology](http://interventionalnews.com/wp-content/uploads/sites/13/2025/07/Merit-Medical-logo-766x512.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/merit-medical-to-acquire-pentax-medicals-c2-cryoballoon-technology/*

## L’essentiel

Pentax Medical has today announced an asset purchase agreement with Merit Medical Systems for the acquisition of the C2 CryoBalloon technology. The C2 CryoBalloon has been part of Pentax Medical&#8217;s therapeutic portfolio since 2017, offering a minimally invasive option to treat patients suffering from Barrett&#8217;s Esophagus and other gastrointestinal disorders.

## Lien source

https://interventionalnews.com/merit-medical-to-acquire-pentax-medicals-c2-cryoballoon-technology/
